stockrow
Saturday 7 November 2026
Export CGNX’s income statement to Excel — free account
Cognex Corporation
CGNX Technology Scientific & Technical Instruments
Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
- Revenue
- +13.2%
- EPS
- +358.2%
- Free cash flow
- +20.6%
Quarter to September 2026, against a year earlier
47.78
0.28
+0.59%
Follow CGNX
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
52.14 | 57.84 | 61.12 | 38.34 | 48.91 | 79.23 | 47.49 | 30.45 | 60.18 | 35.95 |
Piotroski F-Score |
8 | 6 | 6 | 6 | 6 | 5 | 5 | 7 | 7 | 6 |
Altman Z-Score |
8.26 | 9.03 | 9.71 | 11.06 | 16.05 | 16.97 | 12.36 | 28.43 | 35.57 | 45.26 |
P/S ratio |
6.08 | 6.72 | 8.30 | 8.26 | 13.23 | 17.18 | 13.22 | 8.26 | 13.88 | 10.20 |
P/FCF ratio |
25.95 | 49.75 | 87.55 | 38.96 | 47.62 | 63.71 | 43.39 | 37.89 | 57.46 | 34.01 |
Altman Z″-Score (non-manufacturers) |
5.86 | 6.02 | 6.06 | 6.41 | 6.07 | 5.69 | 6.19 | 14.01 | 11.67 | 19.23 |
Beneish M-Score |
(2.78) | (2.39) | (2.48) | (2.61) | (2.53) | (2.53) | (2.35) | (2.57) | (1.88) | (2.39) |
P/Operating CF |
80.72 | 119.60 | 479.51 | 125.42 | 248.54 | 167.93 | 141.60 | 92.86 | 126.22 | 71.60 |
Dividend Safety Score |
84 | — | — | — | — | — | — | — | — | — |
P/B ratio |
4.05 | 4.05 | 4.62 | 5.78 | 9.60 | 11.04 | 7.08 | 5.87 | 9.71 | 5.61 |
Price to Tangible BV |
5.90 | 5.90 | 6.96 | 7.02 | 11.66 | 13.89 | 8.94 | 6.59 | 10.97 | 6.29 |
EV/Sales |
5.74 | 6.45 | 7.90 | 7.86 | 12.92 | 16.72 | 12.65 | 7.60 | 13.36 | 9.40 |
EV/EBITDA |
29.64 | 39.86 | 42.87 | 29.21 | 39.37 | 68.36 | 55.02 | 25.24 | 37.06 | 29.37 |
EV/Operating CF |
23.26 | 39.59 | 58.60 | 32.50 | 42.66 | 55.93 | 36.25 | 27.43 | 45.61 | 27.35 |
EV/FCF |
24.50 | 47.76 | 83.37 | 37.09 | 46.50 | 62.01 | 41.53 | 34.84 | 55.28 | 31.36 |
Quick Ratio |
2.64 | 2.30 | 2.94 | 2.80 | 2.41 | 3.76 | 4.28 | 7.17 | 4.65 | 7.24 |
Current Ratio |
3.80 | 3.62 | 4.47 | 3.82 | 3.39 | 4.55 | 5.04 | 8.54 | 5.59 | 8.00 |
Net Debt/EBITDA |
(1.75) | (1.66) | (2.15) | (1.48) | (0.95) | (1.88) | (2.47) | (2.21) | (1.47) | (2.48) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.50 | 0.46 | 0.42 | 0.51 | 0.55 | 0.44 | 0.46 | 0.63 | 0.66 | 0.55 |
Operating CF/Net income |
2.15 | 1.40 | 1.00 | 1.13 | 1.12 | 1.38 | 1.24 | 1.02 | 1.27 | 1.27 |
Capex/Depreciation |
(0.07) | (0.46) | (0.98) | (0.80) | (0.61) | (0.48) | (0.90) | (1.71) | (1.67) | (0.83) |
| 7.61% | 7.03% | 7.69% | 15.03% | 20.79% | 13.46% | 16.37% | 19.66% | 17.17% | 16.07% | |
| 5.71% | 5.29% | 5.70% | 10.88% | 14.71% | 9.56% | 12.84% | 17.01% | 15.19% | 14.92% | |
ROIC |
8.80% | 5.66% | 6.97% | 14.82% | 17.80% | 11.98% | 9.44% | 23.05% | 23.41% | 17.77% |
Return on Tangible Assets |
19.08% | 19.57% | 17.89% | 35.35% | 52.93% | 32.12% | 35.38% | 28.10% | 29.68% | 27.93% |
Average Days of Receivables |
53.85 | 57.22 | 49.75 | 45.50 | 45.88 | 56.57 | 52.04 | 53.94 | 56.88 | 38.21 |
Research and Development Expense of Revenue |
13.98% | 15.29% | 16.64% | 14.03% | 13.05% | 16.15% | 16.46% | 14.44% | 12.95% | 14.78% |
Selling, General and Administrative Expense of Revenue |
36.59% | 40.56% | 40.49% | 31.02% | 29.83% | 32.99% | 37.74% | 32.58% | 28.81% | 31.37% |
Intangible Assets out of Total Assets |
0.23 | 0.24 | 0.25 | 0.13 | 0.13 | 0.14 | 0.15 | 0.10 | 0.10 | 0.10 |
Share Based Compensation of Revenue |
4.88% | 5.73% | 6.54% | 5.42% | 4.22% | 5.26% | 6.28% | 5.10% | 4.17% | 3.88% |
Graham Net Nets |
0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.01 | 0.09 | 0.04 | 0.08 |
Graham Number |
11.74 | 11.11 | 11.39 | 15.27 | 17.03 | 12.88 | 14.50 | 13.72 | 12.05 | 10.57 |
Earnings Yield |
1.92% | 1.73% | 1.64% | 2.61% | 2.04% | 1.26% | 2.11% | 3.28% | 1.66% | 2.78% |
Free Cash Flow Yield |
3.85% | 2.01% | 1.14% | 2.57% | 2.10% | 1.57% | 2.30% | 2.64% | 1.74% | 2.94% |
Revenue per Share |
5.92 | 5.33 | 4.86 | 5.80 | 5.88 | 4.67 | 4.24 | 4.68 | 4.42 | 3.10 |
Operating CF per Share |
1.46 | 0.87 | 0.66 | 1.40 | 1.78 | 1.40 | 1.48 | 1.30 | 1.29 | 1.07 |
Capex per Share |
(0.01) | (0.09) | (0.13) | (0.11) | (0.09) | (0.08) | (0.13) | (0.22) | (0.17) | (0.08) |
Free Cash Flow per Share |
1.45 | 0.78 | 0.52 | 1.29 | 1.69 | 1.32 | 1.35 | 1.08 | 1.13 | 0.99 |
Cash per Share |
2.01 | 1.44 | 1.93 | 2.31 | 1.83 | 2.15 | 2.41 | 3.11 | 2.33 | 2.47 |
Shareholders Equity per Share |
8.88 | 8.85 | 8.74 | 8.29 | 8.10 | 7.28 | 7.92 | 6.59 | 6.32 | 5.64 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
8.88 | 8.85 | 8.74 | 8.29 | 8.10 | 7.28 | 7.92 | 6.59 | 6.32 | 5.64 |
Free Cash Flow |
243.48 | 134.04 | 89.84 | 223.74 | 298.61 | 229.10 | 231.57 | 186.36 | 195.57 | 169.27 |
Working Capital |
513.70 | 443.99 | 527.11 | 529.99 | 451.21 | 469.39 | 486.75 | 688.97 | 517.36 | 460.57 |
Capital Expenditures |
(2.04) | (15.04) | (23.08) | (19.67) | (15.45) | (13.30) | (21.74) | (37.09) | (28.75) | (12.82) |
Net Current Asset Value |
172.59 | 138.02 | 165.94 | 197.95 | 66.23 | 63.19 | 77.01 | 625.92 | 437.91 | 450.34 |
EV/EBIT |
35.12 | 51.29 | 50.62 | 32.12 | 42.52 | 79.50 | 64.39 | 27.71 | 39.53 | 32.32 |
Capex to Sales |
0.00 | 0.02 | 0.03 | 0.02 | 0.01 | 0.02 | 0.03 | 0.05 | 0.04 | 0.02 |
Price to Operating Income |
37.19 | 53.43 | 53.16 | 33.75 | 43.55 | 81.68 | 67.28 | 30.14 | 41.09 | 35.05 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.35 | 0.34 | 0.22 | 0.31 | 0.32 | 0.35 | 0.27 | 0.24 | 0.22 | 0.29 |
Cash ROIC |
13.31% | 7.60% | 4.89% | 12.17% | 17.03% | 14.02% | 13.10% | 11.15% | 13.04% | 12.24% |
Accounts Receivable Turnover |
6.86 | 7.10 | 6.99 | 7.87 | 8.10 | 7.08 | 6.52 | 6.76 | 8.76 | 10.78 |
Accounts Payable Turnover |
7.46 | 9.70 | 9.73 | 7.99 | 9.19 | 12.09 | 11.13 | 10.38 | 11.25 | 14.82 |
Inventory Turnover |
2.23 | 1.81 | 1.66 | 2.41 | 3.19 | 3.41 | 2.64 | 2.73 | 3.95 | 4.08 |
Average Days of Payables |
55.70 | 48.10 | 33.14 | 34.81 | 57.99 | 28.77 | 34.37 | 28.75 | 45.73 | 27.37 |
Days of Inventory on Hand |
152.99 | 199.15 | 250.67 | 157.31 | 148.89 | 107.56 | 115.91 | 147.53 | 132.37 | 75.14 |
Average Receivables |
145.04 | 128.76 | 119.79 | 127.88 | 128.02 | 114.57 | 111.31 | 119.28 | 87.41 | 49.14 |
Average Payables |
44.12 | 29.75 | 24.28 | 35.58 | 30.16 | 17.07 | 17.05 | 19.85 | 16.65 | 8.85 |
Average Inventory |
147.71 | 159.91 | 142.38 | 117.79 | 86.97 | 60.55 | 71.77 | 75.60 | 47.45 | 32.16 |
Average Assets |
2,004.70 | 2,005.33 | 1,987.98 | 1,980.90 | 1,902.18 | 1,843.32 | 1,587.80 | 1,288.71 | 1,163.18 | 963.18 |
Average Common Equity |
1,504.70 | 1,511.13 | 1,471.57 | 1,434.24 | 1,346.15 | 1,308.96 | 1,245.49 | 1,115.47 | 1,029.14 | 894.13 |
Columns are period end dates · fundamentals updated 6 Nov 2026